134 related articles for article (PubMed ID: 6389592)
1. Rabbit antiserum to a citric acid extract of human skeletal muscle staining thymomas from myasthenia gravis patients.
Gilhus NE; Aarli JA; Christensson B; Matre R
J Neuroimmunol; 1984 Nov; 7(1):55-64. PubMed ID: 6389592
[TBL] [Abstract][Full Text] [Related]
2. Thymic lymphoepitheliomas and skeletal muscle expressing common antigen(s).
Gilhus NE; Matre R; Aarli JA; Hofstad H; Thunold S
Acta Neurol Scand; 1986 Apr; 73(4):428-33. PubMed ID: 2425540
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies.
Gilhus NE; Aarli JA; Matre R
Acta Neurol Scand; 1983 Nov; 68(5):328-36. PubMed ID: 6364682
[TBL] [Abstract][Full Text] [Related]
4. A striational muscle antigen and myasthenia gravis-associated thymomas share an acetylcholine-receptor epitope.
Marx A; Osborn M; Tzartos S; Geuder KI; Schalke B; Nix W; Kirchner T; Müller-Hermelink HK
Dev Immunol; 1992; 2(2):77-84. PubMed ID: 1379503
[TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodies.
Gilhus NE; Aarli JA; Matre R
Neurology; 1984 Feb; 34(2):246-9. PubMed ID: 6363971
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis. Antibodies to skeletal muscle cell surface antigens.
Gilhus NE; Aarli JA; Matre R
J Neuroimmunol; 1983 Dec; 5(3):239-49. PubMed ID: 6361067
[TBL] [Abstract][Full Text] [Related]
7. [Detection of antibodies to citric acid extract of skeletal muscle (CAE-ab) in the sera of patients with myasthenia gravis using indirect hemagglutination].
Ma W
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):143-5, 189. PubMed ID: 2390884
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical localization of thymosin-alpha 1 in thymic epithelial cells of normal and myasthenia gravis patients and in thymic cultures.
Dalakas MC; Engel WK; McClure JE; Goldstein AL; Askanas V
J Neurol Sci; 1981 May; 50(2):239-47. PubMed ID: 7014787
[TBL] [Abstract][Full Text] [Related]
9. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma.
Chen P; Wang YP; Mou DL; Li ZY; Qu QM; Wang HY; Deng Y; Li XF; Wang T; Xu XH; Zhao G
Pathol Oncol Res; 2018 Jan; 24(1):67-74. PubMed ID: 28299711
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis.
Gilhus NE; Aarli JA; Janzen RW; Otto HF; Fasske E; Matre R
J Neuroimmunol; 1985 May; 8(2-3):69-78. PubMed ID: 3998123
[TBL] [Abstract][Full Text] [Related]
11. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin.
Aarli JA; Stefansson K; Marton LS; Wollmann RL
Clin Exp Immunol; 1990 Nov; 82(2):284-8. PubMed ID: 2242609
[TBL] [Abstract][Full Text] [Related]
12. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis.
Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD
Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741
[TBL] [Abstract][Full Text] [Related]
13. CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?
Aarli JA; Gilhus NE; Hofstad H
Acta Neurol Scand; 1987 Jul; 76(1):55-7. PubMed ID: 3630645
[TBL] [Abstract][Full Text] [Related]
14. Muscle nicotinic acetylcholine receptor mRNA expression in hyperplastic and neoplastic myasthenia gravis thymus.
MacLennan CA; Beeson D; Willcox N; Vincent A; Newsom-Davis J
Ann N Y Acad Sci; 1998 May; 841():407-10. PubMed ID: 9668266
[No Abstract] [Full Text] [Related]
15. The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis.
Peers J; McDonald BL; Dawkins RL
Clin Exp Immunol; 1977 Jan; 27(1):66-73. PubMed ID: 321160
[TBL] [Abstract][Full Text] [Related]
16. In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis.
Aime C; Cohen-Kaminsky S; Berrih-Aknin S
J Clin Immunol; 1991 Sep; 11(5):268-78. PubMed ID: 1795043
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Bcl-2 protein in the myasthenic thymus.
Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups.
Hofstad H; Ulvestad E; Gilhus NE; Matre R; Aarli JA
Acta Neurol Scand; 1992 Apr; 85(4):233-8. PubMed ID: 1585794
[TBL] [Abstract][Full Text] [Related]
19. Immunopathological study related to myoglobin in myasthenic and non-myasthenic thymuses.
Koeda T
Acta Pathol Jpn; 1986 Feb; 36(2):209-23. PubMed ID: 3518335
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diagnostic value for the detection of thymoma.
Kuks JB; Limburg PC; Horst G; Dijksterhuis J; Oosterhuis HJ
J Neurol Sci; 1993 Nov; 119(2):183-8. PubMed ID: 8277333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
